Quick Facts at a Glance
- Recall Date
- February 13, 2026
- Hazard Level
- HIGH
- Brand
- Medtronic MiniMed
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- Medtronic MiniMed
- Product type
- Insulin Pump
- Model numbers
- MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892, MiniMed 770G Insulin Pump
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
February 13, 2026
Reported by FDA DEVICE
April 8, 2026
RecallRadar source check
April 15, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter
About This Product
This insulin pump delivers continuous subcutaneous insulin to people with diabetes. The MiniMed 770G and related pumps are used to automate insulin delivery.
Why This Is Dangerous
The device’s height relative to the infusion site can alter insulin flow due to hydrostatic and hydrodynamic pressure changes. Over-delivery risks hypoglycemia and death; under-delivery risks hyperglycemia, dehydration, DKA, and death.
Industry Context
This recall is not stated as part of a broader industry pattern.
Real-World Impact
Consumers could face life-threatening diabetes complications if the device mis-delivers insulin. The recall involves a large, global population of users.
Practical Guidance
How to identify if yours is affected
- Identify your pump model and serial or UDI labels.
- Compare your model against the affected list (MMT-1880, 1881, 1882, 1890, 1891, 1892).
- Check packaging and device labels for model numbers and UDI codes.
Where to find product info
Look on the device label, user guide, and original packaging for model numbers and UDI. Manufacturer recall notices will detail next steps.
What timeline to expect
Refund or replacement processing will follow manufacturer instructions; typical recall timelines range from several weeks to a few months.
If the manufacturer is unresponsive
- Document all communications with the manufacturer.
- Contact your healthcare provider for interim insulin management guidance.
- If the manufacturer is nonresponsive, file a consumer complaint with federal safety agencies.
How to prevent similar issues
- Avoid purchasing older Paradigm, 600 series, or BLE 700 series pumps for replacement until updated guidance is issued.
- Verify recall status before replacing devices.
- Ask clinicians about non-pump insulin management during a recall window.
Documentation advice
Keep the recall notice, your pump’s model and serial numbers, purchase receipts, and all communications with the manufacturer and healthcare providers.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
Product: MiniMed 770G Insulin Pump Brand: Medtronic MiniMed Models: MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892 Distribution: Worldwide, including US states and international markets Original recall date: 2026-02-13 Recall number: Z-1742-2026 Quantity: 95,704 units Associated series: Paradigm, 600 series, BLE 700 series URL: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-1742-2026 Price: Unknown Sold since: Unknown
Reported Incidents
No injuries or incidents have been reported.
Key Facts
- 95,704 units recalled worldwide
- Affects Paradigm, 600 series, and BLE 700 series pumps
- Recall date 2026-02-13; active status
- Over-delivery can cause severe hypoglycemia and death; under-delivery can cause severe hyperglycemia
- Stop using immediately and follow manufacturer instructions
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.